Respiratory Medicine
Volume 104, Issue 4 , Pages 600-605 , April 2010

Chest low-dose computed tomography in neutropenic acute myeloid leukaemia patients

  • Demetris Patsios

      Affiliations

    • Department of Medical Imaging, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada
    • Corresponding Author InformationCorresponding author at: University Health Network, Toronto Western Hospital, McL Wing, 3rd Floor, Room 428, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. Tel.: +1 416 603 5800x2583; fax: +1 416 603 4257.
    • These two authors contributed equally to this paper.
    • ,
  • Nimrod Maimon

      Affiliations

    • Joint Division of Respirology, Department of Medicine, University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
    • These two authors contributed equally to this paper.
    • ,
  • TaeBong Chung

      Affiliations

    • Department of Medical Imaging, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada
    • ,
  • Heidi Roberts

      Affiliations

    • Department of Medical Imaging, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada
    • ,
  • Patricia Disperati

      Affiliations

    • Department of Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, ON M5G 2M9, Canada
    • ,
  • Mark Minden

      Affiliations

    • Department of Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, ON M5G 2M9, Canada
    • ,
  • Narinder Paul

      Affiliations

    • Department of Medical Imaging, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada

Received 20 February 2008 ,Accepted 9 November 2009.

References 

  1. Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious disease. 6th ed.. Churchill Livingstone; 2004;
  2. Soubani A, Miller K, Hassoun P. Pulmonary complications of bone marrow transplantation. Chest. 1996;109:1066–1077
  3. Breuer R, Lossos IS, Berkman N, et al. Pulmonary complications of bone marrow transplantation. Respir Med. 1993;87:571–579
  4. Rosenow EC, Wilson WR, Cockrill FR. Pulmonary diseases in the immunocompromised host. Mayo Clin Proc. 1985;60:473–487
  5. Cordonnier C, Bernaudin JF, Bierling P, et al. Pulmonary complications occurring after allogenic bone marrow transplantation: a study of 130 consecutive transplanted patients. Cancer. 1986;58:1047–1054
  6. Maimon N, Almog Y. Pulmonary infiltrates in the immunocompromised host. IMAJ. 2003;5(2):112–115
  7. Shorr AF, Susla GM, O'Grady NP. Pulmonary infiltrates in the non-HIV-infected immunocompromised patient etiologies, diagnostic strategies, and outcomes. Chest. 2004;125:260–271
  8. Von Eiff M, Zuhlsdorf M, Roos N, et al. Pulmonary infiltrates in patients with hematologic malignancies: clinical usefulness of non-invasive bronchoscopic procedures. Eur J Haematol. 1995;54:157–162
  9. Eriksson B-M, Dahl H, Wang F-Z, et al. Diagnosis of pulmonary infections in immunocompromised patients by fiberoptic bronchoscopy with bronchoalveolar lavage and serology. Scand J Infect Dis. 1996;28:479–485
  10. Dunagan DP, Baker AM, Hurd DD, et al. Bronchoscopic evaluation of pulmonary infiltrates following bone marrow transplantation. Chest. 1997;111:135–141
  11. Prasoon J, Sunder S, Yvonne M, et al. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest. 2004;125:712–722
  12. Cunningham I. Pulmonary infections after bone marrow transplantation. Semin Respir Infect. 1992;7(2):132–138
  13. Krowka MJ, Rosenaw EC, Hoagland HC. pulmonary complications of bone marrow transplantation. Chest. 1985;87:237–245
  14. Maschmeyer G, Link H, Hiddemann W, et al. Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer. 1. 1994;73(9):2296–2304
  15. Harari S. Current strategy in the treatment of invasive Aspergillus infections in immunocompromised patients. Drugs. 1999;58:621–631
  16. Kang EY, Staples CA, McGuinness G, Primack SL, Muller NL. Detection and differential diagnosis of pulmonary infections and tumors in patients with AIDS: value of chest radiography versus CT. AJR Am J Roentgenol. 1996;166(1):15–19
  17. Primack SL, Muller NL. High resolution computed tomography in acute diffuse lung disease in the immunocompromised patient. Radiol Clin North Am. 1994;33(4):731–744
  18. Ambrosino MM, Roche KJ, Genieser NB, Kaul A, Lawrence RM. Application of thin-section low-dose chest CT (TSCT) in the management of pediatric AIDS. Pediatr Radiol. 1995;25:393–400
  19. De Pauw BE. Treatment of documented and suspected neutropenia-associated invasive fungal infections. J Chemother. 13 Spec No. 2001;1:181–192
  20. Rolston KV. Management of infections in the neutropenic patient. Annu Rev Med. 2004;55:519–526
  21. Klastersky J. Science and pragmatism in the treatment and prevention of neutropenic infection. J Antimicrob Chemother 41 suppl D. 1998;13–24
  22. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer. 2004;100:228–237
  23. Lin S, Schranz J, Teutsch S. Aspergillus case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32:358–366
  24. Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis: disease spectrum, treatment practices and outcomes. Medicine. 2000;79:250–260
  25. Costa C, Costa J-M, Desterke C, Botterel F, Cordonnier C, Bretagne S. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microbiol. 2002;40(6):2224–2227
  26. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol. 2002;20:1898–1906
  27. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis. 2005;40:1762–1769
  28. Rolston KV. The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol. 2001;13:218–223
  29. Logan PM, Primack SL, Staples C, Miller RR, Muller NL. Acute lung disease in the immunocompromised host. Diagnostic accuracy of the chest radiograph. Chest. 1995;108:1283–1287
  30. Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001;176:289–296
  31. Haaga JR. Radiation dose management: weighing risk versus benefit. AJR Am J Roentgenol. 2001;177:289–291
  32. Naidich DP, Marshall CH, Gribbin C, Arams RS, McCauley DI. Low-dose CT of the lungs: preliminary observations. Radiology. 1990;175:729–731
  33. Mayo JR, Hartman TE, Lee KS, Primack SL, Vedal S, Muller NL. CT of the chest: minimal tube current required for good image quality with the least radiation dose. AJR Am J Roentgenol. 1995;164:603–607
  34. Mayo JR, Kim KI, MacDonald SL, et al. Reduced radiation dose helical chest CT: effect on reader evaluation of structures and lung findings. Radiology. 2004;232(3):749–756
  35. Mayo JR, Whittall KP, Leung AN, et al. Simulated dose reduction in conventional chest CT: validation study. Radiology. 1997;202:453–457
  36. Takahashi M, Maguire WM, Ashtari M, et al. Low-dose spiral computed tomography of the thorax: comparison with the standard-dose technique. Invest Radiol. 1998;33:68–73
  37. Miller WT, Shah RM. Isolated diffuse ground-glass opacity in thoracic CT: causes and clinical presentations. AJR Am J Roentgenol. 2005;184:613–622

PII: S0954-6111(09)00366-7

doi: 10.1016/j.rmed.2009.11.003

Respiratory Medicine
Volume 104, Issue 4 , Pages 600-605 , April 2010

Article Tools

* Image Usage & Resolution